Abstract:Emerging evidence suggests potential disease modifying roles of ATXN1 , ATXN2 , and ATXN3 in amyotrophic lateral sclerosis (ALS). We aimed to provide a comprehensive variants profile of the ATXN1 , ATXN2 , and ATXN3 genes and examine the association of these variants with the risk and clinical characteristics of ALS. We screened and analyzed the rare variants in a cohort of 2220 ALS patients from Southwest China, using controls from the Genome Aggregation Database (gnomAD) and the China Metabolic Analytics Project (ChinaMAP). The over-representation of rare variants and their association with disease risk in ALS patients were assessed using Fisher's exact test with Bonferroni correction at both allele and gene levels. Kaplan–Meier analysis was employed to explore the relationship between the distribution of variants and survival. A total of 62 eligible rare missense variants were identified, comprising 32 from ATXN1 , 21 from ATXN2 , and 9 from ATXN3 . Allelic association testing revealed a significant enrichment of the ATXN1 (c.2122C > G, p.Leu708Val) variant and the ATXN2 (c.3778C > G, p.Pro1260Ala) variant in ALS. Gene burden analysis indicated that variants in the ATXN1 and ATXN3 genes had a higher burden in ALS. Substantial heterogeneity in survival time was observed among patients carrying different variants within the same gene. However, there were no significant differences in survival between ALS patients grouped by N-terminal or C-terminal distribution. Our results provided a genetic variation profile of ATXN1 , ATXN2 , and ATXN3 in ALS patients, along with the clinical characteristics of individuals carrying these variations. This information might offer valuable insights for the ongoing ALS disease-modifying treatments.

Mutation Analysis of GLT8D1 and ARPP21 Genes in Amyotrophic Lateral Sclerosis Patients from Mainland China

Mutation screening and burden analysis of GLT8D1 in Chinese patients with amyotrophic lateral sclerosis

Mutation screening and burden analysis of GLT8D1 in Chinese patients with ALS

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

GLT8D1 may not be significant in Chinese sporadic amyotrophic lateral sclerosis patients

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Mutation Analysis of MFSD8 in an Amyotrophic Lateral Sclerosis Cohort from Mainland China

Mutation Screening of the GLE1 Gene in a Large Chinese Cohort of Amyotrophic Lateral Sclerosis Patients

Association Analysis of Four Candidate Genetic Variants with Sporadic Amyotrophic Lateral Sclerosis in a Chinese Population

Role of Genetics in Amyotrophic Lateral Sclerosis: a Large Cohort Study in Chinese Mainland Population.

CHCHD10 Mutations in Patients with Amyotrophic Lateral Sclerosis in Mainland China.

Lack of Association of TP73 Rare Variants with Amyotrophic Lateral Sclerosis in a Chinese Cohort

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

Rare, Pathogenic Variants in LRP10 Are Associated with Amyotrophic Lateral Sclerosis in Patients from Mainland China.

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

Dctn1 Gene Analysis In Chinese Patients With Sporadic Amyotrophic Lateral Sclerosis

Mutation Screening of ATXN1, ATXN2, and ATXN3 in Amyotrophic Lateral Sclerosis

Mutation and Clinical Analysis of the CLCC1 Gene in Amyotrophic Lateral Sclerosis Patients from Central South China.

Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia

Mutation Screening of SPTLC1 and SPTLC2 in Amyotrophic Lateral Sclerosis

Mutation spectrum of amyotrophic lateral sclerosis in Central South China